Mike Dunn, MBA, is the President and Chief Operating Officer at Calcimedica (NASDAQ: CALC). Prior to joining Calcimedica Mr. Dunn held senior management positions as Senior VP Corporate Development at Biocept, Inc., as well as VP and Chief Business Officer at Monogram Biosciences and ACLARA Biosciences, and VP of Business Development at Aurora Biosciences. He also served as the VP of Business Development at the Salk Institute Biotechnology and Industrial Associates Inc. (SIBIA). Mr. Dunn obtained his MBA in Finance at the University of San Diego and BA in Biology at the University of Chicago.
Dr. Guzman, is the CEO of Valora Therapeutics and the former CEO of Rakuten Medical, a privately held company that he founded (formerly AspyrianTherapeutics) to develop an innovative photoimmunotherapy platform for the treatment of solid tumor cancers. Dr. Guzman obtained his PhD in Neuroscience at the University of Alicante Institute of Neurosciences in Valencia, Spain.
Dr. McCormack, Founder of Arisan Therapeutics, serves as Chief Executive Officer, managing preclinical, clinical and corporate operations, and held previous scientific and management positions at Narogen, Icagen and Vertex Pharmaceuticals. Dr. McCormack obtained his PhD in Biology at the California Institute of Technology.
Dr. McCormack, oversees the preclinical and clinical development programs, and corporate operations.
Mr. Judd oversees operations, program management, and government business development activities.For nearly 25 years he previously led medical countermeasureprograms against biological threats funded by NIAID, BARDA, DARPA, and the U.S. Department of Defense at Battelle. Mr. Judd is a retired United States Army officer and held appointment as Assistant Professor in the Department ofChemistry and Life Sciences at the U.S. Military Academy at West Point. Mr. Judd holds an M.S. in Microbial Engineering from the University of Minnesota and is a certified Project Management Professional (PMP).
Dr. Piccirillo directsand provides oversight of Arisan’s clinical efforts, withover 30 years of experience over a broad array of therapeutic indications as a Clinical Research Physicianin the medical and clinical research industry; spanning investigative sites, the sponsor side, and contract research organizations. Dr. Piccirillo graduated with a Medical Doctor degree,honorsdiploma,from University of Buenos Aires, Argentina.
Mr. Heredia and the California Counsel Group provide general and corporate counsel for Arisan. Mr. Heredia obtained a JD in law and an MBA from Stanford University after obtaining a BA in Economics-Business from the University of California at Los Angeles.
Arisan’s development efforts are conducted by a teamof dedicated scientific and clinical staff supported by a host of highly experienced consultants and collaborators.